Entera Bio Ltd. – NASDAQ:ENTX
Entera Bio Ltd. stock price today
$1.92
-0.22
-10.7%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
Entera Bio Ltd. stock price monthly change
+13.16%
month
Entera Bio Ltd. stock price quarterly change
+13.16%
quarter
Entera Bio Ltd. stock price yearly change
+241.27%
year
Entera Bio Ltd. key metrics
Market Cap | 77.38M |
Enterprise value | 13.70M |
P/E | -2.31 |
EV/Sales | 55.72 |
EV/EBITDA | 2.13 |
Price/Sales | 105.39 |
Price/Book | 2.20 |
PEG ratio | -0.39 |
EPS | -0.28 |
Revenue | N/A |
EBITDA | -8.69M |
Income | -8.71M |
Revenue Q/Q | N/A |
Revenue Y/Y | 6690.90% |
Profit margin | 2480.49% |
Oper. margin | -8191.87% |
Gross margin | 23.58% |
EBIT margin | -8191.87% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEntera Bio Ltd. stock price history
Entera Bio Ltd. stock forecast
Entera Bio Ltd. financial statements
| Jun 2023 | 0 | -2.32M | |
|---|---|---|---|
| Sep 2023 | 0 | -2.37M | |
| Dec 2023 | 4.48M | -1.99M | -44.51% |
| Mar 2024 | 0 | -2.01M |
| Mar 2024 | 0 | -2.01M | |
|---|---|---|---|
| Sep 2025 | 0 | -4.45M | |
| Oct 2025 | 0 | -5.51M | |
| Dec 2025 | 0 | -7.34M |
Analysts Price target
Financials & Ratios estimates
| 2023-03-27 | -0.11 | 0.21 |
|---|
| Jun 2023 | 10445000 | 2.21M | 21.19% |
|---|---|---|---|
| Sep 2023 | 8565000 | 2.32M | 27.19% |
| Dec 2023 | 11765000 | 1.37M | 11.72% |
| Mar 2024 | 10239000 | 1.37M | 13.44% |
| Jun 2023 | -1.55M | -1K | 5K |
|---|---|---|---|
| Sep 2023 | -1.52M | 185 | -77 |
| Dec 2023 | -2.50M | -4.78K | 6.03M |
| Mar 2024 | -1.86M | 0 | 29.99K |
Entera Bio Ltd. alternative data
| Aug 2023 | 18 |
|---|---|
| Sep 2023 | 19 |
| Oct 2023 | 19 |
| Nov 2023 | 19 |
| Dec 2023 | 19 |
| Jan 2024 | 19 |
| Feb 2024 | 19 |
| Mar 2024 | 17 |
| Apr 2024 | 17 |
| May 2024 | 17 |
| Jun 2024 | 17 |
| Jul 2024 | 17 |
Entera Bio Ltd. other data
0.08%
-10.51%
of ENTX is owned by hedge funds
22.00K
-3.02M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Apr 2023 | 30000 | 0 |
| Aug 2023 | 78000 | 0 |
| Dec 2023 | 95808 | 0 |
| Jan 2024 | 24730 | 0 |
| Patent |
|---|
Application Filling date: 31 Jan 2022 Issue date: 19 May 2022 |
Application Filling date: 23 Dec 2019 Issue date: 7 May 2020 |
Grant Filling date: 9 Feb 2016 Issue date: 10 Mar 2020 |
Application Filling date: 21 Aug 2019 Issue date: 19 Dec 2019 |
Grant Filling date: 6 Jun 2018 Issue date: 24 Sep 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2022 18 May 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 8 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Q2 2021 16 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q4 2020 18 Mar 2021 | Q4 2020 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Phillip Schwartz Ph.D. (1962) Executive Vice President, Pres of R&D and Director | $441,000 |
Dr. Hillel Galitzer (1978) Chief Operating Officer | $359,000 |
Dr. Arthur C. Santora II, M.D., Ph.D. (1951) Chief Medical Officer | $355,000 |
-
What's the price of Entera Bio Ltd. stock today?
One share of Entera Bio Ltd. stock can currently be purchased for approximately $1.92.
-
When is Entera Bio Ltd.'s next earnings date?
Unfortunately, Entera Bio Ltd.'s (ENTX) next earnings date is currently unknown.
-
Does Entera Bio Ltd. pay dividends?
No, Entera Bio Ltd. does not pay dividends.
-
How much money does Entera Bio Ltd. make?
Entera Bio Ltd. has a market capitalization of 77.38M. Entera Bio Ltd. made a loss 8.89M US dollars in net income (profit) last year or $0.21 on an earnings per share basis.
-
What is Entera Bio Ltd.'s stock symbol?
Entera Bio Ltd. is traded on the NASDAQ under the ticker symbol "ENTX".
-
What is Entera Bio Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Entera Bio Ltd.?
Shares of Entera Bio Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Entera Bio Ltd.'s key executives?
Entera Bio Ltd.'s management team includes the following people:
- Dr. Phillip Schwartz Ph.D. Executive Vice President, Pres of R&D and Director(age: 63, pay: $441,000)
- Dr. Hillel Galitzer Chief Operating Officer(age: 47, pay: $359,000)
- Dr. Arthur C. Santora II, M.D., Ph.D. Chief Medical Officer(age: 74, pay: $355,000)
-
How many employees does Entera Bio Ltd. have?
As Jul 2024, Entera Bio Ltd. employs 17 workers.
-
When Entera Bio Ltd. went public?
Entera Bio Ltd. is publicly traded company for more then 7 years since IPO on 28 Jun 2018.
-
What is Entera Bio Ltd.'s official website?
The official website for Entera Bio Ltd. is enterabio.com.
-
How can i contact Entera Bio Ltd.?
Entera Bio Ltd. can be reached via phone at +972 2 532 7151.
Entera Bio Ltd. company profile:
Entera Bio Ltd.
enterabio.comExchange:
NASDAQ
Full time employees:
17
Industry:
Biotechnology
Sector:
Healthcare
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Kiryat Hadassah Minrav Building
Jerusalem, 9112002
Jerusalem, 9112002
CIK: 0001638097
ISIN: IL0011429839
CUSIP: M40527109
